Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 3, 2018
April 11, 2024
287c413c-cc5e-49ee-af83-9d7183bc4f4d
Related Documents
Pediatric HIV Infection: Drug Development for Treatment
Guidance DocumentMarch 20, 2019Center for Drug Evaluation and Research
Duchenne Muscular Dystrophy and Related Dystrophinopathies: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentFebruary 16, 2018Center for Drug Evaluation and Research
Clinical Trial Imaging Endpoint Process Standards Guidance for Industry
Guidance DocumentApril 27, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.